KEAP1 and ovarian cancer: Transfection with inhibitors of miR141, as well as of inhibitors of miR-200c, in ovarian cancer cell lines induced cell resistance to paclitaxel and carboplatin (375); however, it has been described that expression of miR-141, via regulating KEAP1, can increase resistance to cisplatin chemotherapy in ovarian cancer cells (374).